Clinical Trial Update: MK0429 Study in Prostate Cancer Patients With Metastatic Bone Disease (0429-011) [Phase 1]

View source ↗

Summary

Phase 1 trial of MK0429 in prostate cancer with metastatic bone disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastases
• Prostate Cancer

Drugs mentioned

• MK0429

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Prostatic Neoplasms | Phase 1 | Status: COMPLETED